MABPHARM-B (02181.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Aug28

MABPHARM-B released FY2025 Q1 earnings on August 28 (BJT), actual revenue HKD 146.82 M, actual EPS HKD 0.0003

15:00

MABPHARM-B released FY2025 Semi-Annual Earnings on August 28 During-Market (BJT), Actual Revenue: HKD 296.87 M, Actual EPS: HKD 0.0007

08:00

MABPHARM-B released FY2025 Q2 earnings on August 28 During-Market BJT, actual revenue HKD 150.05 M, actual EPS HKD 0.0003

08:00

Aug20

MABPHARM-B to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

01:58

Mar26

MABPHARM-B released FY2024 annual earnings on March 26 (BJT), actual revenue 279.53 M HKD, actual EPS -0.0335 HKD

15:00

MABPHARM-B released FY2024 9 Months Earnings on March 26 (BJT), with actual revenue of 200.06 M HKD and EPS of -0.031 HKD

15:00

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 150.05 M, Net Income 1.586 M, EPS 0.0003

Mar26

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 79.65 M, Net Income -16.16 M, EPS -0.0053

Aug28

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 58.28 M, Net Income -52.42 M, EPS -0.0127

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More